Table 1:
Designed Chimeric Peptides and Result of Structural modeling
Hemextin A (peptide) | Terminal link | Chimera (HA p + Lazarus p) | Structure Analysis |
---|---|---|---|
1. | |||
A- LVPFLSKTAPEG | COOH-terminal | LVPFLSKTAPEG + EEWEVLCWTWETCERGEGVEEELWEWR | No recognisable fold was obtained |
B- LVPFLSKTAPEG | NH2-terminal | EEWEVLCWTWETCERGEGVEEELWEWR + LVPFLSKTAPEG | No recognisable fold was obtained |
2. | |||
A- TCPEGKNLCYKMTMLKMPKI | COOH-terminal | TCPEGKNLCYKMTMLKMPKI + EEWEVLCWTWETCERGEGVEEELWEWR | No recognisable fold was obtained |
B- TCPEGKNLCYKMTMLKMPKI | NH2-terminal | EEWEVLCWTWETCERGEGVEEELWEWR + TCPEGKNLCYKMTMLKMPKI | No recognisable fold was obtained |
3. | |||
A- KIPIKRGCTDACPKS | COOH-terminal | KIPIKRGCTDACPKS + EEWEVLCWTWETCERGEGVEEELWEWR | No recognisable fold was obtained |
B- KIPIKRGCTDACPKS | NH2-terminal | EEWEVLCWTWETCERGEGVEEELWEWR + KIPIKRGCTDACPKS | Distinct fold wasobserve wafter modeling |
4. | |||
A- TCPEGKNLCYKMTMLKMCKIPIK | COOH-terminal | TCPEGKNLCYKMTMLKMCKIPIK + EEWEVLCWTWETCERGEGVEEELWEWR | Distinct fold was observe wafter modeling |
B- TCPEGKNLCYKMTMLKMCKIPIK | NH2-terminal | EEWEVLCWTWETCERGEGVEEELWEWR + TCPEGKNLCYKMTMLKMCKIPIK | Distinct fold was observe wafter modeling |
5. | |||
A- LVPFLSKTCCEGKNLCYKMTMLKMPKI | COOH-terminal | LVPFLSKTCCEGKNLCYKMTMLKMPKI + EEWEVLCWTWE TCERGEGVEEELWEWR | Distinct fold was observe wafter modeling |
B- LVPFLSKTCCEGKNLCYKMTMLKMPKI | NH2-terminal | EEWEVLCWTWETCERGEGVEEELWEWR + LVPFLSKTCCEGKNLCYKMTMLKMPKI | Distinct fold was observe wafter modeling |
6. | |||
A- KMPKICIKRGCTDACPKS | COOH-terminal | KMPKICIKRGCTDACPKS + EEWEVLCWTWETCERGEGVEEELWEWR | No recognisable fold was obtained |
B- KMPKICIKRGCTDACPKS | NH2-terminal | EEWEVLCWTWETCERGEGVEEELWEWR + KMPKICIKRGCTDACPKS | No recognisable fold was obtained |
Notes: + denotes the nine alanine spacer; HA p denotes the peptide fragment derived from hemextin A; Lazarus p denotes the peptide designed at Genentech CA, USA by Dr Bob Lazarus and his colleagues.